CollPlant Biotechnologies (CLGN) Return on Sales (2017 - 2026)
CollPlant Biotechnologies' (CLGN) quarterly Return on Sales came in at 0.43% in Q1 2026, down 42.0% YoY from 0.74% in Q1 2025, and up 91.99% on a QoQ basis from 5.33% in Q4 2025.
CollPlant Biotechnologies (CLGN) Return on Sales (2017 - 2026) Analysis & Trends
CollPlant Biotechnologies (CLGN) has 10 years of Return on Sales data on file, last reported at 0.43% in Q1 2026.
- Quarterly Return on Sales fell 42.0% year-over-year to 0.43% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.91% (down 88.0% YoY) and the FY2025 annual result came in at 0.17%, up 59.0% from the prior year.
- Return on Sales advanced to 0.43% in Q1 2026, from 5.33% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.43% in Q1 2024 to a low of 11.24% in Q3 2024.
- A 5-year average of 1.42% and a median of 0.23% in 2024 frame the typical range for Return on Sales.
- Annual changes were most pronounced in 2024 — Return on Sales tumbled 1124 bps — and 2025, when it soared 1078 bps.
- Tracing CLGN's Return on Sales over 5 years: stood at 4.68% in 2022, then surged by 96 bps to 0.17% in 2023, then slumped by 71 bps to 0.29% in 2024, then sank by 1754 bps to 5.33% in 2025, then surged by 92 bps to 0.43% in 2026.
- The last three Return on Sales figures came in at 0.43% (Q1 2026), 5.33% (Q4 2025), and 0.46% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | CollPlant Biotechnologies | 4.13 Mn | 4.13 Mn | -243,000.00 | -0.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | -0.43% |
| Dec 31, 2025 | -5.33% |
| Sep 30, 2025 | -0.46% |
| Jun 30, 2025 | 0.18% |
| Mar 30, 2025 | -0.01% |
| Dec 31, 2024 | -0.29% |
| Sep 30, 2024 | -11.24% |
| Jun 30, 2024 | 0.16% |
| Mar 31, 2024 | 0.43% |
| Dec 31, 2023 | -0.17% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.01% |
| Mar 31, 2023 | 0.07% |
| Dec 31, 2022 | -4.68% |
| Sep 30, 2022 | -0.41% |
| Jun 30, 2022 | -0.63% |
| Dec 31, 2021 | -7.36% |
| Sep 30, 2021 | 5.14% |
| Jun 30, 2021 | -0.04% |
| Mar 31, 2021 | 0.01% |